ESC Premium Access

Estimating preventive treatment effect in individual patients from a lifetime perspective: the aspirin example

Topic: Primary cardiovascular prevention: interventions and outcomes

Congress Presentation

About the speaker

Doctor Jannick Dorresteijn

University Medical Center Utrecht, Utrecht (Netherlands (The))
3 presentations
0 follower

4 more presentations in this session

State of the art in current cardiovascular disease prevention

Speaker: Professor J. Deanfield (London, GB)


The effects of statins on cardiovascular outcomes by smoking status. a systematic review and meta-analysis of randomized controlled trials.

Speaker: Associate Professor S. Ursoniu (RO)


Meta-analysis of non-invasive screening for coronary artery disease in asymptomatic patients with diabetes

Speaker: Doctor O. Clerc (Boston, US)


Future direction for research in cardiovascular disease prevention

Speaker: Professor C. Bairey Merz (Los Angeles, US)


Access the full session

Improving cardiovascular disease prevention

Speakers: Doctor J. Dorresteijn, Professor J. Deanfield, Associate Professor S. Ursoniu, Doctor O. Clerc, Professor C. Bairey Merz

About the event


ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb